/Investor DB

Pictet Group — 2025 Investments

3 investments dated 2025 · listed companies and verified rows first · show all

Azafarosazafaros.comMay 2025✓ verified

Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions.

BiotechDeep TechHealthtechMedical DevicesLeiden, NL

Hans Aerts(Professor)Hermen Overkleeft(Professor)Stan van Boeckel(Professor)

Co-investorsBioGeneration VenturesBioMedPartnersForbionJeito CapitalAsahi Kasei Corporate Venture CapitalSeroba Life Sciences

Mainspring Energymainspringenergy.cominApr 2025

Mainspring Energy develops power generation systems.

Deep TechEnergyHardware

Shannon Miller(Founder)inAdam Simpson(Founder)Matt Svrcek(Founder)

BoardTom Linebarger(Chairman & Chief Executive Officer)

Co-investorsKhosla VenturesAlumni VenturesClearSkyDCVC (Data Collective)Fine Structures VenturesGeneral Catalyst+6 more

Unique AIunique.chinFeb 2025

Unique provides a platform that accelerates business processes and go-to-market initiatives through generative AI applications and consulting expertise for enterprise clients.

AI & Machine LearningEnterprise SoftwareFintechSaaSZurich, CH

Andreas Hauri(Founder)inManuel Grenacher(Founder)inMichelle Heppler(Founder)in

Co-investorsCommerzVenturesDaniel GutenbergDN CapitalKickstart InnovationVI PartnersFYRFLY Venture Partners+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.